68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series
نویسندگان
چکیده
منابع مشابه
Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer
Objective(s): 99mTc-PSMA SPECT/CT is a cost effective alternative for 68Ga-PSMA PET/CT. The aim of this study was to directly compare these two techniques in patients with prostate cancer. Methods: 28 man with prostate cancer were studied using 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in a shor...
متن کاملDiagnostic Challenges in Prostate Cancer and 68Ga-PSMA PET Imaging: A Game Changer?
Prostate cancer (PC) is the most frequent solid tumor in men and the third most common cause of cancer mortality among men in developed countries. Current imaging modalities like ultrasound (US), computerized tomography (CT), magnetic resonance imaging (MRI) and choline based positron emission (PET) tracing have disappointing sensitivity for detection of nodal metastasis and small tumor recurre...
متن کاملIntegration of 68Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study
BACKGROUND Prostate cancer (PC) is one of the most commonly treated cancer entities with radiation therapy (RT). Risk group-adapted treatment and avoidance of unnecessary toxicities relies primarily on accurate tumor staging. Thus, the introduction of prostate-specific membrane antigen (PSMA) in diagnosis and treatment of PC is a highly interesting development in radiation oncology of urologic ...
متن کاملManual production and quality control of 68Ga-PSMA-11 radiopharmaceutical for PET-CT imaging of prostate cancer: optimization and 60 production series experience
Background: 68Ga-PSMA-11, a novel PET radiopharmaceutical, is currently used for imaging of almost all prostate cancers. However, automatic radiolabeling procedures have been recommended. In this research, according to the chemical nature of the PSMA-11, manual, optimized and safe production of this radiopharmaceutical has been investigated and a standard method has been presented to achieve a ...
متن کامل68Ga-PSMA PET/CT imaging in recurrent prostate cancer: Where are we now?
INTRODUCTION Prostate cancer (PCa) is a major health concern worldwide with up to 60% of patients experiencing biochemical relapse after radical treatment. Early diagnosis of PCa recurrence is of high importance for successful salvage therapy. The need for accurate imaging has prompted the introduction of prostate-specific membrane antigen (PSMA)-based radiotracers for positron emission tomogra...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Nuclear Medicine and Molecular Imaging
سال: 2020
ISSN: 1619-7070,1619-7089
DOI: 10.1007/s00259-020-04783-1